CYP 4.26% 22.5¢ cynata therapeutics limited

Hi Varky,You can start at looking the company website.About...

  1. 3,993 Posts.
    lightbulb Created with Sketch. 1329
    Hi Varky,

    You can start at looking the company website.

    About Cymerus

    The trademark Cymerus refers to the patented process of generating cell-based products from intermediate cells, known as mesenchymoangioblasts (MCAs), which in turn are derived from induced pluripotent stem cells (iPSCs). This technology was originally developed at the University of Wisconsin-Madison (UWM), a world-renowned leader in stem cell research.

    The means of producing MCAs from pluripotent precursors, and the defining pattern of MCA cell surface markers, are the subjects of US patent 7,615,374, and a number of other patent applications in process around the world, licensed to or owned by Cynata.

    At present, Cynata is focussed on the production of mesenchymal stem cell (MSC)-based products using the Cymerus technology.


    https://www.cynata.com/about-cymerus

    https://www.cynata.com/

    Regards

    Rossi70
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.010(4.26%)
Mkt cap ! $40.41M
Open High Low Value Volume
23.5¢ 23.5¢ 22.5¢ $11.57K 49.51K

Buyers (Bids)

No. Vol. Price($)
2 100000 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 7426 1
View Market Depth
Last trade - 15.43pm 10/05/2024 (20 minute delay) ?
Last
23.0¢
  Change
-0.010 ( 0.00 %)
Open High Low Volume
23.0¢ 23.5¢ 23.0¢ 10710
Last updated 15.01pm 10/05/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.